RHY 1.67% 6.1¢ rhythm biosciences limited

In answer to your questions, may I respectfully suggest that you...

  1. 280 Posts.
    lightbulb Created with Sketch. 95
    In answer to your questions, may I respectfully suggest that you read the report in full, and check the criteria.

    Might you have considered cost as an interim barrier for a hasty FDA application? The CLIA lab pathway provides revenue while at they simultaneously accumulate real world statistics in preparation for FDA. It's a very clever strategy.
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.